Stopping ADHD medication: what happens and how to plan it

Adults stop ADHD medication for many reasons: side effects, a pregnancy or plans for one, cost, a pharmacy shortage, a new job, or simply wanting to know how they do without it. Stopping is common. A 2024 study of prescription records from eight countries and Hong Kong found that only about 48% of adults aged 25 and over, and 39% of those aged 18 to 24, were still taking ADHD medication one year after starting, although many restarted later. This page explains what FDA labels say about stopping, what research shows about symptoms returning, and why the decision works better as a plan made with the prescriber. It does not tell you whether to stop, and it contains no dosing information.

What the labels say about stopping

The answer depends on the medication. FDA labels describe three quite different situations.

Stimulants

Since the 2023 class labeling update, stimulant labels list withdrawal signs after abrupt discontinuation or dose reduction following prolonged use: dysphoric (low, uneasy) mood, depression, fatigue, vivid and unpleasant dreams, sleeping too little or too much, increased appetite, and either slowed movement or agitation. These signs are distinct from the return of ADHD symptoms, although the two can overlap in the first days.

Atomoxetine

The current Strattera label states that no taper is needed when discontinuing it, and that there was no evidence of symptom rebound or a discontinuation syndrome. It also tells prescribers who use it for extended periods to reevaluate its long-term usefulness for each patient from time to time. More detail is on the Strattera page.

Guanfacine

Extended-release guanfacine was studied for ADHD in children and adolescents aged 6 to 17, so its use in adults is off-label. Its label is the clearest warning about stopping suddenly: rebound hypertension, and in some cases hypertensive encephalopathy (a dangerous rise in blood pressure affecting the brain), were reported after abrupt discontinuation. The label tells prescribers to advise patients not to stop without consulting their health care provider. See guanfacine and clonidine for ADHD in adults.

Will ADHD symptoms come back?

For many people, yes, at least partly. ADHD medication treats symptoms while it is being taken. It does not cure the condition.

• Vyvanse adult maintenance study. Adults who had taken lisdexamfetamine for at least six months and were responding were randomly assigned to keep taking it or switch to placebo. Over six weeks, 75% of those switched to placebo met the study's definition of treatment failure, compared with 9% who stayed on the medication, according to the Vyvanse label.
• A review of withdrawal studies. Across randomized withdrawal studies of several ADHD medications in children and adults, relapse was more common and came sooner on placebo. The review suggested symptoms returned more slowly after stopping atomoxetine than after stopping stimulants or guanfacine, though study designs differed.
• Some people do well without it. In a Dutch study of children and adolescents who had taken methylphenidate for more than two years, 40.4% of those withdrawn to placebo worsened, compared with 15.9% who continued. The authors noted that some individuals can stop without deterioration and that periodic reassessment is reasonable.

The practical lesson is that nobody can predict in advance how you will do. That is why a planned trial, with a way to measure the result, is more useful than stopping and hoping.

Why plan it with your prescriber

UK guidance from NICE recommends that ADHD medication be reviewed at least once a year, with a discussion of whether to continue. It encourages people to raise any preference to stop or change, and it recommends considering trial periods of stopping or reducing the dose when the balance of benefits and harms suggests this may be appropriate. A planned trial lets the prescriber:

• decide whether a gradual reduction makes sense for your particular medication
• check blood pressure and pulse where the label calls for it
• agree in advance on what will count as "this is not working"
• choose a time that does not fall on your highest-stakes weeks
• arrange a follow-up so you are not left without a plan if symptoms return

A simple plan for a trial off medication

1. Write down why. Side effects, pregnancy plans, cost and "I want to see" lead to different plans.
2. Get a baseline. Rate your symptoms now, using the same scale from your evaluation if you have it.
3. Agree on the method and timing with the prescriber, including whether to reduce gradually.
4. Tell one person you trust who can notice changes you might miss.
5. Track for several weeks: focus, missed deadlines, mood, sleep, appetite, driving and any withdrawal signs.
6. Book the follow-up before you start, and bring your notes.

Unplanned stops: shortages and running out

Sometimes medication stops because it cannot be filled. As of October 2026, the FDA lists mixed amphetamine salts immediate-release, lisdexamfetamine and methylphenidate extended-release as being in shortage. In New York, Schedule II prescriptions cannot be refilled, so every fill needs a new prescription. If your pharmacy is out of stock, contact the prescriber quickly instead of rationing or stretching tablets. See what to do in an ADHD medication shortage and lost or stolen ADHD medication.

Missed follow-ups can also interrupt prescriptions. New Jersey's P.L.2026, c.40 requires adult Schedule II stimulant patients located in New Jersey who start by telehealth to have an in-person visit within 30 days, a contact every three months and an in-person visit at least yearly. Telehealth ADHD prescriptions in New Jersey explains the rule.

Pregnancy and breastfeeding

Pregnancy is a common reason to reconsider medication, and it is a decision to make with the prescriber and obstetric clinician together, ideally before conception. Stimulant labels advise patients to tell their health care provider if they become pregnant or plan to, and the Qelbree label advises discontinuing it when pregnancy is recognized unless the benefits outweigh the potential risk. The NY guide covers this in ADHD in pregnancy and postpartum.

Restarting after a break

Do not go back to your previous amount on your own after a gap. The guanfacine label, for example, tells prescribers to consider building back up gradually after two or more missed consecutive doses. Ask the prescriber how to restart any ADHD medication after a break.

When to contact the prescriber or get emergency care

• Contact the prescriber if you notice low mood, exhaustion, sleep changes or agitation that last more than a few days after stopping, or if ADHD symptoms return enough to affect work, driving or relationships.
• Call or text 988 at any hour if you have thoughts of harming yourself.
• Call 911 for a severe headache, confusion, chest pain or fainting, especially after stopping guanfacine suddenly.

Leftover tablets should not stay in a drawer. The FDA recommends drug take-back options first and gives instructions for disposal at home when take-back is not available.

Dr. Shershow, a psychiatrist licensed in New York and New Jersey who focuses on adult ADHD, provides ongoing medication management and follow-up by secure video. Read about adult ADHD treatment or contact the office.